CellaVision AB (publ) (CLVSF) Stock Price, News & Analysis

Company Overview

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software. The DM-series instruments capture high-resolution images of cells, which are then analyzed and pre-classified by the company’s patented image recognition algorithms. The CellaVision software suite provides a user-friendly interface for manual review, annotation and reporting, facilitating remote collaboration and quality control. In addition to hardware and software, CellaVision offers training, maintenance and technical support services to ensure effective integration and ongoing system performance in laboratory settings.

CellaVision serves hospitals, reference laboratories and academic institutions across Europe, North America, Asia-Pacific and Latin America through a combination of direct sales offices and distribution partnerships. In October 2021, the company was acquired by Danaher Corporation, integrating its digital morphology expertise into Danaher’s life sciences portfolio. This strategic alignment has expanded CellaVision’s global reach and reinforced its commitment to advancing hematology diagnostics through innovation and collaboration.

Key Stats

• Today's Range: $19.28 to $19.28
• 50-Day Range: $19.28 to $19.28
• 52-Week Range: $19.28 to $19.91
• Volume: N/A
• Average Volume: 383 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CLVSF Stock Analysis - Frequently Asked Questions

How have CLVSF shares performed this year?

CellaVision AB (publ)'s stock was trading at $19.91 at the start of the year. Since then, CLVSF stock has decreased by 3.2% and is now trading at $19.2796.

How do I buy shares of CellaVision AB (publ)?

Shares of CLVSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CLVSF
• CIK: N/A
• Web: www.cellavision.com
• Phone: (646) 460-1600
• Fax: N/A
• Employees: 223
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A